Novozymes North America, Inc.
Location
North Carolina
Founded
1969-02-28
Website
Risk Signals
989 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial Organic Chemicals, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novozymes North America, Inc.
Live alerts from global media, monitored by Business Radar
2025-02-05 (catedraavicola.com.ar)
Novonesis: La fusión of the giants that impels La Innovación en la Industria -
In this new installment of poultry & agricultural chair we will know in detail the company Novonesis, merger of Christian Hansen and Novozymes, global leaders in the production of bacteria and enzymes respectively. It highlights the extensive career and sustainable commitment of Christian Hansen - recognized as the most sustainable company in the world in 2019 - and the position of Novozymes as the main developer of enzymes internationally.
Read more
2025-01-29 (bt.dk)
Big Danish merger exactly one year ago: This is how the share price has been done | BT MONEY -
Exactly a year ago, business history was written at home when the two stock exchange companies Chr. Hansen and Novozymes merged together and became one.
Read more
2025-01-23 (food-supply.dk)
The merger between Chr. Hansen and Novozymes are moving closer
The merger between Chr. Hansen and Novozymes get the green light in the US, the companies write in a press release.
Read more
2025-01-07 (borsen.dk)
Novonesis storms forward - turnover approaching DKK 40 billion. DKK before 2028
Novonesis storms forward - turnover approaching DKK 40 billion. DKK before 2028 It is going well to merge the competences from the two companies Novozymes and Chr. Hansen, which in 2024 was finally laid to rest
Read more
2024-11-07 (proinvestor.com)
Novonesis surprises with clarification in strong third quarter
Novonesis more or less came out of the third quarter of 2024 than expected. However, the joker was a clarification of the expectations for the whole year. This appears from the trading update from the group, which consists of the old Chr. Hansen and Novozymes after a successful merger. The enzyme and ingredient group
Read more
2024-11-07 (fodevarewatch.dk)
Novonesis raises the bottom of expectations for 2024
Novonesis, which is the merger between Novozymes and Chr. Hansen, expects organic sales growth at the upper end of 7-8 per cent. in 2024.
Read more
2024-10-26 (naturalproductsinsider.com)
Pioneering the future of human health through biosolutions
In a landmark merger that marks the largest in Danish history, Novozymes and Chr. Hansen have joined forces to create Novonesis, a global leader in biosolutions. This powerful combination brings together more than 100 years of innovation and expertise, positioning Novonesis to address some of
Read more
2024-10-25 (dieharke.de)
New name in Nienburg: Chr. Hansen is now called Novonesis and is the market leader
Chr. Hansen and Novozymes become Novosenis: This is what the merger means for the Nienburg location.
Read more
2024-10-23 (solutions-numeriques.com)
Benchling and Novonesis join forces to transform global biotechnology R&D
Recently, the cloud software publisher for R&D in the biotechnology industry, Benchling, partnered with a global leader in biosolutions, Novonesis. This partnership allows Novonesis to deploy the Benchling digital platform to its 1,500 scientists, in order to support the
Read more